Multicentral phase II study of adjuvant UFT/LV chemotherapy with completely resected rectal cancer.
Phase 2
Recruiting
- Conditions
- Rectal cancer
- Registration Number
- JPRN-UMIN000011954
- Lead Sponsor
- Division of Surgical Oncology, Department of Surgery, Faculty of Medicine, Tottori University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with severe surgical complication. 2)Phenytoin, warfarin potassium, or flucytosin administration. 3)Allergic more than and equal to grade3. 4)Patients with significant complications. 5)History of serious allergic reaction with UFT. 6)Lactating, pregnant or possibly pregnant women, and men who have willing to become partner's pregnant. 7)Patients with HIV,HBV. 8)Not appropriate for the study at the physician's assessment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3y RFS
- Secondary Outcome Measures
Name Time Method OS, Safety, treatment completion rate